Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients
- PMID: 39616008
- DOI: 10.1016/j.clml.2024.11.002
Presence of 1q21 Gain and Amplification May be Associated With Poorer Outcomes in Daratumumab-treated Multiple Myeloma Patients
Publication types
LinkOut - more resources
Full Text Sources